BioMarin to lay off 170 staffers after pipeline reorg
Less than a month after revealing pipeline cuts amid disappointing gene therapy sales, BioMarin is now downsizing its team.
The biotech said it will lay …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
